Netherlands· NL-3807b18cf0aa

Emtriva 10 mg/ml, drank

A emtricitabine product containing emtricitabine, registered in Netherlands by Gilead Sciences Ireland UC. The same ATC class is registered in 13 of our 19 countries.

ATC J05AF09

Checked against CBG-MEB (Netherlands) on September 29, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about emtricitabineAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Emtricitabine is registered in 13 of 19 countries.

Countries holding a registration under ATC J05AF09 (emtricitabine), each read from that country’s own register.

This record: Netherlands, from CBG-MEB (Netherlands)
9 of them publish a price we can compare per daily dose

Search emtricitabine products by name

Emtricitabine · ATC J05AF09

13 / 19 countries

Belgiumprice
Czechiaprice
Denmark
Finlandprice
Franceprice
Icelandprice
Ireland
Netherlands
Norwayprice
Polandprice
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of emtricitabine costs, country by country.

Normalised to the WHO defined daily dose (0.2 g), so markets compare like for like.

1 market with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Emtricitabine · price per daily dose (0.2 g)

USD · FX 28 Sept 2026

CH Switzerland$8.60

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)

Active substance: EMTRICITABINE
Manufacturer: Gilead Sciences Ireland UC
Country: Netherlands (NL)
ATC code: J05AF09
ATC class: Emtricitabine
Defined daily dose: 0.2 g, O
Reimbursed: Not published by this register
Source register: CBG-MEB (Netherlands)
Last checked: September 29, 2026

Packs & prices · 1

cbg_meb_id
EU/1/03/261

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

32 interactions on record for emtricitabine.

Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check emtricitabine against other medicines How interaction checks work

Emtricitabine · interactions on record

32 records

4 severe
23 moderate
1 minor

Most severe, free to view

LeflunomidL04AA13severe
TeriflunomidL04AA31severe
LeflunomideL04AK01severe
TeriflunomideL04AK02severe

4 more interactions with mechanism and management, from a commercially licensed source.

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Emtricitabine in 13 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All emtricitabine products

Authorised across Europe · EMA

The same active substance is authorised in 4 EEA countries. Names it is sold under:

Spain · Emtricitabina/Tenofovir Alafenamida Dr. Reddys
Iceland · Emtriva
Liechtenstein · Emtriva
Norway · Emtriva

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/81c79cbe-26f6-448e-9dfd-af697583dbf9
GET /v1/drugs/81c79cbe-26f6-448e-9dfd-af697583dbf9?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Drank",
  "route": "Oraal gebruik",
  "soort": null,
  "source": "cbg_meb",
  "smpc_url": "https://www.ema.europa.eu/en/documents/product-information/emtriva-epar-product-information_nl.pdf",
  "strength": null,
  "atc_label": "Emtricitabine",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp71781",
  "excipients": [
    "COTTON CANDY FLAVOUR F-9967",
    "DINATRIUMEDETAAT 2-WATER",
    "METHYLPARAHYDROXYBENZOAAT (E 218)",
    "NATRIUMDIWATERSTOFFOSFAAT 1-WATER (E 339)",
    "NATRIUMHYDROXIDE (E 524)",
    "PROPYLEENGLYCOL (E 1520)",
    "PROPYLPARAHYDROXYBENZOAAT",
    "WATER, GEZUIVERD",
    "XYLITOL (E 967)",
    "ZONNEGEEL FCF (E 110)",
    "ZOUTZUUR (E 507)"
  ],
  "substances": [
    "EMTRICITABINE"
  ],
  "leaflet_url": null,
  "authorised_at": "2003/10/24",
  "procedure_number": "EMEA/H/C/000533",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "EU/1/03/261",
  "additional_monitoring": "N"
}

API reference MCP server Plans

See everything about emtricitabine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console